ortoxine Report issue

Small molecule Experimental
ChEMBL Drug Central KEGG MeSH PubChem

Active Ingredient History

Methoxyphenamine also known as 2-methoxy-N-methylamphetamine (OMMA), is a beta adrenergic receptor agonist nd is used as a bronchodilator to treat asthma, chronic obstructive pulmonary disease (COPD) and postinfectious cough. In addition, methoxyphenamine using is prohibited in sports according to the regulations of the World Anti-Doping Agency (WADA).   NCATS

Chemistry

More Chemistry

Pharmacology

Alternative names

1-(2-methoxyphenyl)-2-methylaminopropane | 2-methoxymethamphetamine | 2-methoxy-n,alpha-dimethylphenethylamine | methoxiphenadrin | methoxyphenadrine | methoxyphenamin | methoxyphenamine | methoxyphenamine hcl | methoxyphenamine hydrochloride | methoxyphenamine hydrochloride, (+-)-isomer | methoxyphenamine hydrochloride, (r)-isomer | methoxyphenamine, (s)-isomer | mimexina | orthoxine | ortodrinex | ortoxine

Indications (3)

Approved Indications (3)


 

Asthma

Cough

Pulmonary Disease, Chronic Obstructive

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue